[ad_1]
29/10/2018
QIAGEN N.V. (NYSE: QGEN, Frankfurt Prime Standard: QIA) announced today the
Third quarter and third quarter operating results
first nine months 2018 known. According to the data, progress has been made
with regard to the achievement of the targets set for 2018 and
the global expansion of the portfolio "sample to insight" for molecular badysis
Test solutions across the spectrum – from basic research to
to clinical health care.
The full press release can be found here
Look at the original version on businesswire.com: https://www.businesswire.com/news/home/20181029005754/de/
List of live clbades, BSNgine
Stocks on the radar: Amag . Palfinger . composite . Buwog . Rosenbauer . Zumtobel . Warimpex . Strabag . Petro World Technologies . Mayr-Melnhof . EVN . Agrana . AT & S . FACC . Kapsch TrafficCom . Souche Oberbank AG ,
Random partner
Evotec
Evotec is a drug discovery and development company engaged in the development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and pharmaceutical companies. venture capital companies.
>> Visit 64 other partners on boerse-social.com/partner
<! –
Posted in:
Business thread
–
Marked with:
->
Source link
